- Nov 7, 2016

Review Supports Dexrazoxane Use for Cardioprotection

The practice of giving dexrazoxane to protect the hearts of pediatric patients receiving anthracycline chemotherapy is supported by a review published in the British Journal of Clinical Pharmacology.

Patient Activated Education Effective as Surveillance for Skin Cancer in Childhood Cancer Survivors

Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders

Low BMD, fracture risk upped in childhood cancer survivors

Understanding How Childhood Brain Tumors Develop

American Academy of Pediatrics Issues New Recommendations on Hospitalized Adolescents

Genes that cause rare hidden cancer revealed

Stopping a rare childhood cancer in its tracks

Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed

New research identifies a potential treatment target for hepatoblastoma in children

Loneliness May Lead to Chronic Conditions Emotional Distress in Young Adult Cancer Survivors

Recent Posts

Review Supports Dexrazoxane Use for Cardioprotection

Archive

Search By Tags